Severe drug-induced hypersensitivity syndrome with a shared HLA-B allele

Medical Journal of Australia

Volumn 197, Issue 7, 2012, Pages 411-413

  Harding, Damian J ^a   Subramaniam, Kavitha ^a   MacQuillan, Gerry ^a,b   Davis, Joshua ^c,d   Nolan, David ^e  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL DARWIN HOSPITAL   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; HLA B ANTIGEN; PHENYTOIN; VALGANCICLOVIR; ANTICONVULSIVE AGENT;

ABDOMINAL PAIN; ABSCESS DRAINAGE; ADULT; ALLELE; ARTICLE; AUSTRALIA; BRAIN ABSCESS; CASE REPORT; COLITIS; COLONOSCOPY; COUGHING; DESQUAMATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DRESS SYNDROME; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; FEVER; GASTROSCOPY; HEPATITIS; HISTOPATHOLOGY; HUMAN; HYPOTENSION; HYPOXEMIA; LUNG INFILTRATE; MALE; MOUTH ULCER; PAPULAR RASH; RESPIRATORY FAILURE; SEIZURE; STOMACH ULCER; VIREMIA; DRUG HYPERSENSITIVITY; GENETICS; SEVERITY OF ILLNESS INDEX;

ADULT; ALLELES; ANTICONVULSANTS; DRUG HYPERSENSITIVITY; FEMALE; HLA-B ANTIGENS; HUMANS; MALE; PHENYTOIN; SEVERITY OF ILLNESS INDEX;

EID: 84871854564     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.10477     Document Type: Article

References (11)

1. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913-D919.
2. Bharadwaj M, Illing P, Theodossis A, et al. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu Rev Pharmacol Toxicol 2012; 52: 401-431.
3. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156: 1083-1084.
4. McCormack M, Alfirevic A, Bourgeois S, et al. HLA-A*3101 and carbamazepineinduced hypersensitivity reactions in Europeans. N Engl J Med 2011; 364: 1134-1143.
5. Kano Y, Ishida T, Hirahara K, Shiohara T. Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome. Med Clin North Am 2010; 94: 743-759.
6. Teraki Y, Shibuya M, Izaki S. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Clin Exp Dermatol 2010; 35: 723-728.
7. Jeung YJ, Lee JY, Oh MJ, et al. Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and Stevens-Johnson syndrome. Allergy Asthma Immunol Res 2010; 2: 123-126.
8. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1-8.
9. Seishima M, Yamanaka S, Fujisawa T, et al. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006; 155: 344-349.
10. Adam J, Pichler WJ, Yerly D. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol 2011; 71: 701-707.
11. Takahashi R, Kano Y, Yamazaki Y, et al. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009; 182: 8071-8079.